AUT-00206

N/A

Report date: 2024/12/04 16:53:38
NME

Base Information

Drug NameAUT-00206
Drug Alias NameAUT-00206
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv3.1 modulatorsPotassium Voltage-Gated Channel Subfamily C Member 2 modulators
TargetsVoltage-gated potassium channel subunit Kv3.1Potassium Voltage-Gated Channel Subfamily C Member 2
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAutifony Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAutifony Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A